Tus-Pharmaceutical Group Co., Ltd. (000590.SZ)

CNY 7.98

(-0.25%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.15 Billion 1.16 Billion 967.82 Million 892.15 Million 846.74 Million 816.59 Million
Total Current Assets 539.55 Million 529.1 Million 553.88 Million 508.61 Million 491.48 Million 486.96 Million
Cash And Short Term Investments 189.76 Million 260.53 Million 325.82 Million 342.95 Million 314.33 Million 321.35 Million
Cash and Cash Equivalents 189.76 Million 235.42 Million 250.68 Million 342.95 Million 314.33 Million 321.35 Million
Short Term Investments - 25.1 Million 75.14 Million - - -
Net Receivables 215.01 Million 147.8 Million 141.45 Million 114.22 Million 125.92 Million 66.85 Million
Inventory 130.08 Million 118.22 Million 86.59 Million 50.82 Million 50.88 Million 69.01 Million
Other Current Assets 4.68 Million 2.55 Million 10.69 Thousand 619.12 Thousand 343.14 Thousand 29.73 Million
Total Non-Current Assets 611.56 Million 637.64 Million 413.94 Million 383.54 Million 355.25 Million 329.63 Million
Net PPE 293.81 Million 289.74 Million 240.88 Million 224.73 Million 200.96 Million 171.34 Million
Good Will And Intangible Assets 263.97 Million 294.58 Million 133.69 Million 138.16 Million 134.7 Million 137.6 Million
Good Will 131.64 Million 137.14 Million - - - -
Intangible Assets 132.32 Million 157.43 Million 133.69 Million 138.16 Million 134.7 Million 137.6 Million
Long-Term Investments 44.61 Million -6.1 Million -56.14 Million 15.74 Million 14.52 Million 2.00
Tax Assets 4.08 Million 4.96 Million 4.97 Million 4.55 Million 2.11 Million 2.38 Million
Other Non Current Assets 5.08 Million 54.46 Million 90.53 Million 340.8 Thousand 2.94 Million 18.29 Million
Other Assets 0.00 - - 1.00 - 1.00
Total Liabilities 380.47 Million 464.25 Million 285.5 Million 247.27 Million 224.58 Million 236.88 Million
Total Current Liabilities 248.77 Million 271.41 Million 186.98 Million 161.01 Million 153.91 Million 141.02 Million
Account Payables 47.58 Million 64.01 Million 41.66 Million 38.62 Million 34.88 Million 26.55 Million
Tax Payables 2.29 Million 16.8 Million 8 Million 7.35 Million 14.22 Million 4.6 Million
Short Term Debt 50.62 Million 38.61 Million 2.99 Million 5 Million -28.9 Million 18 Million
Deferred Revenue 50.12 Million 56.13 Million 132.73 Million 115.57 Million 28.9 Million 4.6 Million
Other Current Liabilities 100.43 Million 112.65 Million 9.58 Million 1.81 Million 119.03 Million 91.86 Million
Total Non Current Liabilities 131.7 Million 192.84 Million 98.52 Million 86.25 Million 70.66 Million 95.85 Million
Long-Term Debt 80 Million 95.17 Million 5.58 Million 9.22 Million - 20 Million
Deferred Revenue Non Current 42.44 Million 44.36 Million 46.28 Million 41.56 Million 38.7 Million 39.03 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 3.34 Million 46.09 Million 46.62 Million 44.69 Million 31.96 Million 2.5 Million
Other Liabilities -0.00 - - - - 1.00
Total Equity 728.2 Million 702.49 Million 682.32 Million 644.88 Million 622.16 Million 579.71 Million
Stock Holders Equity 723.71 Million 698.46 Million 680.32 Million 644.88 Million 622.16 Million 579.71 Million
Common Stock 239.47 Million 239.47 Million 239.47 Million 239.47 Million 239.47 Million 239.47 Million
Retained Earnings -35.71 Million -60.96 Million -79.11 Million -114.55 Million -137.27 Million -179.71 Million
Accumulated other comprehensive income 142.59 Million 142.59 Million 142.59 Million 142.59 Million 142.59 Million 142.59 Million
Common Stock Equity 723.71 Million 698.46 Million 680.32 Million 644.88 Million 622.16 Million 579.71 Million
Capital Lease Obligation 3.07 Million 5.17 Million 5.58 Million 9.22 Million - -
Total Investments 44.61 Million 19 Million 19 Million 15.74 Million 14.52 Million 2.00
Total Debt 133.69 Million 133.79 Million 8.58 Million 5 Million - 38 Million
Net Debt -56.07 Million -101.62 Million -242.09 Million -337.95 Million -314.33 Million -283.35 Million

Balance Sheet Charts